2'-deoxyinosine-5'-monophosphate : A deoxyinosine phosphate that is 5'-inosinic acid in which the hydroxy group at position 2' by a hydrogen atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 135398614 |
| CHEBI ID | 28806 |
| SCHEMBL ID | 1533826 |
| SCHEMBL ID | 20282682 |
| MeSH ID | M0067766 |
| Synonym |
|---|
| 2'-deoxyinosine-5'-monophosphate |
| CHEBI:28806 , |
| 3393-18-8 |
| [(2r,3s,4r,5r)-3-hydroxy-5-(6-hydroxy-9h-purin-9-yl)tetrahydrofuran-2-yl]methyl dihydrogen phosphate |
| 2'-deoxyinosine 5'-monophosphoric acid |
| 9-(2-deoxy-5-o-phosphono-beta-delta-erythro-pentofuranosyl)-9h-purin-6-ol |
| 2'-deoxyinosine 5'-phosphate |
| 2'-deoxy-5'-inosinic acid |
| 9-(2-deoxy-5-o-phosphono-beta-d-erythro-pentofuranosyl)-9h-purin-6-ol |
| 2'-deoxyinosine 5'-monophosphate |
| hypoxanthine deoxyriboside |
| C06196 |
| deoxyinosine monophosphate |
| NCGC00249101-01 |
| unii-t2sls3p7a9 |
| t2sls3p7a9 , |
| einecs 222-237-0 |
| EPITOPE ID:158627 |
| SCHEMBL1533826 |
| {[(2r,3s,5r)-3-hydroxy-5-(6-oxo-6,9-dihydro-3h-purin-9-yl)oxolan-2-yl]methoxy}phosphonic acid |
| deoxyinosine phosphate |
| DTXSID60937065 |
| Q15410932 |
| SCHEMBL20282682 |
| ((2r,3s,5r)-3-hydroxy-5-(6-oxo-3h-purin-9(6h)-yl)tetrahydrofuran-2-yl)methyl dihydrogen phosphate |
| [(2r,3s,5r)-3-hydroxy-5-(6-oxo-1h-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate |
| [(2r,3s,5r)-3-hydroxy-5-(6-oxo-3h-purin-9-yl)tetrahydrofuran-2-yl]methyl dihydrogen phosphate |
| inosine, 2'-deoxy-, 5'-(dihydrogen phosphate) |
| inosine, 2'-deoxy-, 5'-phosphate |
| ((2r,3s,5r)-3-hydroxy-5-(6-oxo-3h-purin-9(6h)-yl)tetrahydrofuran-2-yl)methyldihydrogenphosphate |
| Role | Description |
|---|---|
| Escherichia coli metabolite | Any bacterial metabolite produced during a metabolic reaction in Escherichia coli. |
| human metabolite | Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens). |
| mouse metabolite | Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
| Mycoplasma genitalium metabolite | Any bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| deoxyinosine phosphate | |
| purine 2'-deoxyribonucleoside 5'-monophosphate | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Pathway | Proteins | Compounds |
|---|---|---|
| Purine nucleotides and Nucleosides metabolism ( Purine nucleotides and Nucleosides metabolism ) | 105 | 77 |
| Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-2 | 0 | 490 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||